Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06741865

The INSPIRE -Faith Study: Intervention Strategies for Preserving Intellectual Resilience and Engagement

The INSPIRE-Faith Study, initiated by the Healthy Minds Initiative, is a community-based research project aimed at demonstrating the impact of lifestyle factors on cognitive health and the prevention of dementia. Conducted in collaboration with the American College of Lifestyle Medicine, Charles Drew University, UCLA, Stanford University and Crenshaw Christian Center, this study focuses on all communities that are affected by lifestyle-dependent diseases. The study involves 2,000 participants aged 55 and older and aims to implement targeted community relevant interventions to enhance cognitive function and overall brain health.

Recruiting

Interested in participating?

Request Info

Key information

Age range

55 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Crenshaw Christian Center

Los Angeles, California, 90044, United States

Location status: Recruiting

Location contact

Brenda Bennett

CONTACT

[email protected]

323-758-3777

Dean Sherzai, MD, PhD

PRINCIPAL_INVESTIGATOR

Mohsen Bazargan, PhD

SUB_INVESTIGATOR

About this study

The INSPIRE-Faith Study, led by the Healthy Minds Initiative, is a groundbreaking community-based research project aimed at exploring the relationship between lifestyle factors and cognitive health, with an emphasis on nutrition and dietary intervention, to prevent dementia and cognitive impairment in communities. This study will take start in South Los Angeles, California, a region characterized by the prevalence of lifestyle-dependent diseases but will expand into all of California.

The study, slated to begin in January/February 2025, will involve 2,000 participants aged 55 and older, recruited through community outreach, health education programs, and referrals from local healthcare providers. Participants will undergo a comprehensive initial assessment, including evaluations of medical history, cognitive function, lifestyle habits, and access to health resources.

Participants will be randomized into two groups: an intervention group and a control group. The intervention group will receive personalized guidance from health coaches, participate in an online community forum designed to teach about nutrition and lifestyle risk factor management, and have access to tailored exercise programs, educational materials, and other resources designed to promote cognitive health. The control group will receive standard-of-care educational material and monthly communications aimed at maintaining or improving health. Both groups will undergo baseline assessments and periodic evaluations throughout the study to measure the impact of the interventions on cognitive health.

The Inspire-Faith Study employs a randomized controlled crossover design to promote equity, maximize participant benefit, and enhance retention. Participants will be randomized to either the Guided Lifestyle Intervention Group or the Independent (Standard Health Education) Group for the first 6 months. At the 6-month midpoint, study arms will cross over, such that participants initially assigned to the control condition will receive the guided intervention, and participants initially receiving the guided intervention will transition to the independent condition.

The study is designed to leverage community partnerships with organizations such as the American College of Lifestyle Medicine, Charles Drew University, UCLA, Stanford University and Crenshaw Christian Center. These partnerships provide the necessary infrastructure, expertise, and community trust to ensure the study's success.

The INSPIRE Study's primary goal is to demonstrate how targeted community relevant lifestyle interventions can reduce the risk of cognitive decline in all populations that are vulnerable to such outcomes. By addressing factors such as diet, physical activity, stress management, and social engagement, and management of vascular risk factors, the study aims to create a model for improving brain health that can be replicated in all communities.

The study's findings will not only contribute to the scientific understanding of lifestyle-related cognitive health but also have the potential to inform public health strategies and policy decisions aimed at improving access to health resources and support. The long-term vision is to establish the Healthy Minds Initiative as a leader in brain health for all, with the INSPIRE Study serving as a blueprint for future community interventions.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age: Participants must be 55 years of age or older.
  • Ethnicity: Focused on African American individuals, but not exclusive.
  • Cognitive Status: Participants must have normal cognitive status, mild cognitive impairment (MCI), or subjective cognitive impairment (SCI).
  • Language: Participants must be fluent in English.
  • Location: Must reside in the Crenshaw, California area or* be able to attend study-related activities in this location. *online access is available for those not in this area.
  • Willingness to Participate: Participants must be willing to adhere to the study protocol, including attending assessments, participating in interventions, and completing questionnaires.

Exclusion criteria

  • Cognitive Decline: Diagnosis of dementia or severe cognitive impairment that would interfere with the ability to participate in the study.
  • Physical Limitations: Any physical or medical condition that would preclude participation in the lifestyle interventions (e.g., severe mobility issues).
  • Recent Cancer Diagnosis: Diagnosis of cancer within the last three years, excluding stable cases of basal cell or squamous cell carcinoma of the skin, or stable prostate cancer.
  • Pregnancy: Current pregnancy or planning to become pregnant during the study period.
  • Mental Health: Diagnosis of severe psychiatric disorders such as schizophrenia or bipolar disorder that might interfere with participation.
  • Substance Abuse: Current substance abuse or dependency that could impact participation.
  • Hearing Impairment: Uncorrected hearing loss that would limit the ability to communicate and participate in the study.
  • Non-English Speaking: Inability to participate in English-language oral and written cognitive assessments.
  • Participation in Another Study: Currently enrolled in another clinical trial that could interfere with the INSPIRE Study.
  • Life expectancy less than 3 years
  • Unwillingness to share medical and laboratory information.

Treatment and study plan

Lifestyle Intervention

Behavioral

This arm involves interventions like health coaching, dietary changes, exercise programs, and other lifestyle modifications.

Standard Health Education

Other

Participants in the Standard of Care Arm will receive basic educational materials focused on general cognitive and physical health maintenance.

Primary outcomes

  1. Change in Cognitive Function

    Time frame: 6 months, 1 year and 3 years

    Change in global composite score from baseline, as measured by the TABCAT (Tablet-based Cognitive Assessment Tool) composite score, at the designated endpoint (e.g., 6 months, 1 year, and 3 years). This composite score reflects core domains of cognition-including memory, executive function, language, and processing speed-captured through standardized TABCAT assessments.

Secondary outcomes

  1. Adherence to Lifestyle Interventions

    Time frame: Continuous, with key evaluations at 6 months and 12 months.

    Measure adherence to prescribed diet and exercise changes through self-reported questionnaires and logs maintained by health coaches.

Other outcomes

  1. Change in Blood Pressure

    Time frame: 6 months, 1 year and 3 years

    Evaluate changes in blood pressure, as measured by sphygmomanometer at baseline, and then at 6 months, 1 year and 3 years.

  2. Change in Low Density Lipoprotein (LDL) cholesterol levels

    Time frame: 6 months, 1 year and 3 years

    Evaluate changes in Low Density Lipoprotein, as measured by a lipid panel serum test at baseline, and then at 6 months, 1 year and 3 years.

  3. Change in Hemoglobin A1c markers

    Time frame: 6 months, 1 year and 3 years

    Evaluate changes in serum Hemoglobin A1c, a marker of glucose metabolism dysfunction, as measured in the serum, at baseline and then at 6 months, 1 year and 3 years.

  4. Executive functions composite

    Time frame: 6 months, 1 year and 3 years

    Composite score of executive function cognitive test, as measured by TABCAT.

  5. Episodic Memory Composite

    Time frame: 6 months, 1 year and 3 years

    Composite score of episodic memory cognitive test, as measured by TABCAT.

Study contacts

Contact information is provided by the study sponsor or research team.

Caroline Segalla, BA

CONTACT

[email protected]

808-333-2883

Dean Sherzai, MD, PhD

CONTACT

[email protected]

949-383-6729

Sponsors and collaborators

Lead sponsor

Healthy Minds Initiative

Other

Collaborators

  • American College of Lifestyle Medicine
  • Charles Drew University of Medicine and Science
  • Stanford University
  • University of California, Los Angeles

Registry information

Official study title

Intervention Strategies for Preserving Intellectual Resilience and Engagement

Acronym: INSPIRE -Faith

Important dates

Study start
2025
Primary completion
2028
Study completion
2028
First posted
Dec 19, 2024
Registry last updated
May 28, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.